Meeting
2020 Genitourinary Cancers Symposium
Association of cytoreductive nephrectomy and survival in the immune checkpoint inhibitor era.
Authors
Joseph Miccio
Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT
Joseph Miccio , Sung Jun Ma , Oluwadamilola Temilade Oladeru , Daniel X. Yang , Gabrielle W. Peters , Krishan Jethwa , Henry S. Park , Michael E. Hurwitz , Michael Leapman , Preston Sprenkle , Paul Nguyen , James Yu , Kimberly Johung
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Other
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 748)
Abstract #
748
Poster Bd #
K4
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Subsets of interferon signaling and response to immune checkpoint blockade.
First Author: Daniel Lee
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of cytoreductive nephrectomy (CN) on survival in metastatic renal cell cancer (mRCC) treated with immune checkpoint inhibitors (ICI).
First Author: Stuthi Perimbeti
Poster
2022 ASCO Genitourinary Cancers Symposium
SWOG S1931 (PROBE): Phase III randomized trial of immune checkpoint inhibitor (ICI) combination regimen with or without cytoreductive nephrectomy (CN) in advanced renal cancer.
First Author: Ulka N. Vaishampayan
Poster
2024 ASCO Genitourinary Cancers Symposium
The role of cytoreductive nephrectomy (CN) in the immune checkpoint inhibitor (ICI) era of metastatic renal cell carcinoma (mRCC): A systematic review and individual patient data (IPD) meta-analysis of 2319 patients.
First Author: Dimitrios Makrakis